Celsius (CELH) Q3 2026 Earnings Call Transcript

Celsius Holdings reported Q3 2026 revenue of $847.2 million, up 17% year over year, and net income of $127.0 million versus a $61.0 million loss a year earlier; Alani Nu revenue rose 24% to $410.1 million, while CELSIUS revenue fell 6%. Gross margin declined to 46.8% from 51.3% a year earlier amid higher aluminum and diesel costs, and adjusted diluted EPS fell 2% to $0.41. Management expects Q4 reported revenue growth to be below the first three quarters, citing difficult comparisons and $20 million-$25 million of shipments pulled forward into Q3; it also outlined a 2027 pricing and trade-investment program and repurchased $44.5 million of stock in Q3.

Analysis

The key issue is conversion quality, not headline growth: strong Alani Nu scans coexist with weaker reported growth, while shipments were pulled forward and CELSIUS orders are still trailing scans. That raises the risk that Q4 sell-in disappoints even if consumer demand holds. The market may treat this as timing, but inventory normalization and DSD-related trade investment make the bridge to underlying demand harder to read into early 2027. Alani Nu’s limited-time-offer success is also a concentration risk: if repeat purchase and permanent-SKU velocity do not hold after the seasonal item rolls off, current momentum overstates the durable run rate.

Near term, expect reported-growth and margin pressure to dominate sentiment: management flagged a tougher Q4 comparison, shipment reversal, and elevated aluminum and diesel. Over 1–3 months, monitor tracked-channel sales versus shipments, CELSIUS distribution/productivity, and trade investment. Over 6–18 months, the upside case depends on 2027 innovation, improved price-pack execution, and North Carolina logistics benefits offsetting commodity costs; these are plans, not yet demonstrated margin gains. A plausible competitive spillover is retailers reallocating shelf space toward brands with better velocity, pressuring slower CELSIUS and Rockstar SKUs and giving competitors such as Monster Beverage and Red Bull an opening.

Contrarian view: the Q4 slowdown is substantially foreshadowed and could be less damaging if scans remain healthy; however, the market may underweight how long margin recovery takes. No clean read-through to PepsiCo’s consolidated earnings follows from the distribution relationship alone. Verify that CELH’s scan-to-shipment gap narrows and gross margin stabilizes before underwriting a full recovery.

Key Decisions for Investors

• Keep CELH exposure cautious into Q4; do not extrapolate portfolio revenue growth directly into consumer demand or earnings momentum. Reassess after reported shipments can be compared with tracked-channel sales.
• Treat CELH’s 2027 margin-recovery thesis as conditional. Track gross margin, trade investment as a share of gross sales, aluminum and diesel costs, and evidence that the new price-pack program improves economics without hurting velocity.
• Use Alani Nu’s post-LTO repeat sales and permanent-SKU performance as the key demand test; weakening scans after Witch’s Brew would falsify the view that its strength reflects durable brand recruitment.
• No standalone PEP trade: the article does not establish a material earnings sensitivity for PepsiCo. Monitor CELH distribution execution rather than assuming the partnership guarantees growth.